Fehrenbach Heinz, Tews Sebastian, Fehrenbach Antonia, Ochs Matthias, Wittwer Thorsten, Wahlers Thorsten, Richter Joachim
Department of Internal Medicine (Respiratory Medicine), Philipps-University, Baldingerstrasse, D-35043 Marburg, Germany.
Respir Res. 2005 Jun 21;6(1):60. doi: 10.1186/1465-9921-6-60.
Declining levels of surfactant protein A (SP-A) after lung transplantation are suggested to indicate progression of ischemia/reperfusion (IR) injury. We hypothesized that the previously described preservation-dependent improvement of alveolar surfactant integrity after IR was associated with alterations in intraalveolar SP-A levels.
Using immuno electron microscopy and design-based stereology, amount and distribution of SP-A, and of intracellular surfactant phospholipids (lamellar bodies) as well as infiltration by polymorphonuclear leukocytes (PMNs) and alveolar macrophages were evaluated in rat lungs after IR and preservation with EuroCollins or Celsior.
After IR, labelling of tubular myelin for intraalveolar SP-A was significantly increased. In lungs preserved with EuroCollins, the total amount of intracellular surfactant phospholipid was reduced, and infiltration by PMNs and alveolar macrophages was significantly increased. With Celsior no changes in infiltration or intracellular surfactant phospholipid amount occurred. Here, an increase in the number of lamellar bodies per cell was associated with a shift towards smaller lamellar bodies. This accounts for preservation-dependent changes in the balance between surfactant phospholipid secretion and synthesis as well as in inflammatory cell infiltration.
We suggest that enhanced release of surfactant phospholipids and SP-A represents an early protective response that compensates in part for the inactivation of intraalveolar surfactant in the early phase of IR injury. This beneficial effect can be supported by adequate lung preservation, as e.g. with Celsior, maintaining surfactant integrity and reducing inflammation, either directly (via antioxidants) or indirectly (via improved surfactant integrity).
肺移植后表面活性物质蛋白A(SP-A)水平下降提示缺血/再灌注(IR)损伤进展。我们假设,先前描述的IR后肺泡表面活性物质完整性的保存依赖性改善与肺泡内SP-A水平的改变有关。
采用免疫电子显微镜和基于设计的体视学方法,评估大鼠肺在IR及用EuroCollins或Celsior保存后,SP-A、细胞内表面活性物质磷脂(板层小体)的数量和分布,以及多形核白细胞(PMN)和肺泡巨噬细胞的浸润情况。
IR后,肺泡内SP-A的管状髓磷脂标记显著增加。在用EuroCollins保存的肺中,细胞内表面活性物质磷脂总量减少,PMN和肺泡巨噬细胞的浸润显著增加。使用Celsior时,浸润或细胞内表面活性物质磷脂数量无变化。在此,每个细胞的板层小体数量增加与向较小板层小体的转变有关。这解释了表面活性物质磷脂分泌与合成平衡以及炎症细胞浸润的保存依赖性变化。
我们认为,表面活性物质磷脂和SP-A的释放增强代表了一种早期保护反应,可在IR损伤早期部分补偿肺泡内表面活性物质的失活。这种有益作用可通过适当的肺保存得到支持,例如使用Celsior,直接(通过抗氧化剂)或间接(通过改善表面活性物质完整性)维持表面活性物质完整性并减轻炎症。